Teva Pharmaceutical Industries (TEVA) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to -$3.6 billion.
- Teva Pharmaceutical Industries' Enterprise Value fell 2013.51% to -$3.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.6 billion, marking a year-over-year decrease of 2013.51%. This contributed to the annual value of -$3.6 billion for FY2025, which is 2013.51% down from last year.
- Latest data reveals that Teva Pharmaceutical Industries reported Enterprise Value of -$3.6 billion as of Q4 2025, which was down 2013.51% from -$2.2 billion recorded in Q3 2025.
- Teva Pharmaceutical Industries' Enterprise Value's 5-year high stood at -$768.0 million during Q1 2021, with a 5-year trough of -$3.6 billion in Q4 2025.
- In the last 5 years, Teva Pharmaceutical Industries' Enterprise Value had a median value of -$1.8 billion in 2022 and averaged -$1.9 billion.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Enterprise Value plummeted by 9583.33% in 2024 and then surged by 3800.44% in 2025.
- Teva Pharmaceutical Industries' Enterprise Value (Quarter) stood at -$1.2 billion in 2021, then plummeted by 67.39% to -$2.0 billion in 2022, then decreased by 29.85% to -$2.6 billion in 2023, then dropped by 13.58% to -$3.0 billion in 2024, then decreased by 20.14% to -$3.6 billion in 2025.
- Its Enterprise Value stands at -$3.6 billion for Q4 2025, versus -$2.2 billion for Q3 2025 and -$2.2 billion for Q2 2025.